x
- Whole-Eye Computational Model of the Eye, Patent No: 12/429,149, Publish Date: August 27th, 2012.
- Application of intraoperative tomographic image analysis for ophthalmic surgical planning. (Appl. No.: 2658/CHE/2015).
- Quantification of Bowman's layer for diagnosis of disease and prognosis of treatments in the human cornea. (Appl. No.: 6539/CHE/2015, PCT/IB2016/057422). US patent application granted in 2021.
- A system and method of artificial intelligence and tomography imaging of human cornea. (Appl. No.: 201741008796, TEMP/E-1/8968/2017-CHE). US patent application granted in 2021.
- A method to quantify the quality of corneal donor tissue for transplantation using tomography imaging. (Appl. No.: TEMP/E-1/15839/2017-CHE).
- A method to quantify the corneal parameters to improve biomechanical modeling. (Appl. No.: TEMP/E-1/7686/2018-CHE).
- A device to generate customizable light curing patterns for ophthalmic applications. (Appl. No.: TEMP/E-1/30360/2019-CHE).
- A system for advanced evaluation of progression of disease in ocular tissues. (Appl. No.: TEMP/E1/11807/2020-CHE).
- Set of biomarkers to identify early diabetic retinopathy, retinal angiogenic diseases, and resistance to ocular anti-VEGF therapy. (Granted: Patent No. 423197; Appl. No.: 2251/CHE/2015, Country of filing – India).
- A formulation of combination of genistein and calcitriol for the management of inflammatory ocular surface conditions (Appl. No: 202041030776).
- A topical formulation for alleviating inflammatory and ectatic signs and symptoms for ocular conditions. (Appl. No: 202041039874).
- Angiogenin as a diagnostic or prognostic biomarker and drug target in age-related macular degeneration. (Appl. No: 201641012304, PCT/IB2017/051998).
- Biomarkers for diagnosis of ocular diseases and the method thereof. (Appl. No: PCT/IB2019/054472).
- A quantitative testing of vitamins in tears and topical ophthalmic composition for treatment of ocular diseases. (Appl. No.: 3818/CHE/2015) .
- A process for identification of biomarkers for Keratoconus progression. (Appl. No.: 110/CHE/2013).